Neomycin binding preserves extracellular matrix in bioprosthetic heart valves during in vitro cyclic fatigue and storage

Acta Biomaterialia

Volumn 5, Issue 4, 2009, Pages 983-992

  Raghavan, Devanathan ^a   Starcher, Barry C ^b   Vyavahare, Naren R ^a  

^a AMRL   (United States)

^b UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

Author keywords

Elastin; Glutaraldehyde; Glycosaminoglycans; Heart valve

Indexed keywords

COLLAGEN; CROSSLINKING; ELASTIN; GLYCOPROTEINS; HEART; STORAGE (MATERIALS); TISSUE;

BIOPROSTHETIC HEART VALVES; CHEMICAL CROSS-LINKING; COMPLEX ARCHITECTURES; CYCLIC FATIGUE; EXTRACELLULAR MATRICES; GLUTARALDEHYDE CROSSLINKING; GLUTARALDEHYDES; GLYCOSAMINOGLYCANS; HEART VALVES; IN-VITRO;

ANTIBIOTICS;

2 DEOXYSTREPTAMINE; ELASTIN; GLUTARALDEHYDE; GLYCOSAMINOGLYCAN; NEOMYCIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CROSS LINKING; EXTRACELLULAR MATRIX; FATIGUE; GRAFT PRESERVATION; HEART VALVE BIOPROSTHESIS; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROCESS OPTIMIZATION; SWINE;

EID: 64249166293     PISSN: 17427061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actbio.2008.11.004     Document Type: Article

References (35)

1. Aslam A.K., Aslam A.F., Vasavada B.C., and Khan I.A. Prosthetic heart valves: types and echocardiographic evaluation. Int J Cardiol 122 2 (2007) 99-100
2. Everaerts F., Torrianni M., van Luyn M., van Wachem P., Feijen J., and Hendriks M. Reduced calcification of bioprostheses, cross-linked via an improved carbodiimide based method. Biomaterials 25 24 (2004) 5523-5530
3. Schoen F.J., and Levy R.J. Founder's Award, 25th Annual Meeting of the Society for Biomaterials, perspectives. Providence, RI, April 28-May 2, 1999. Tissue heart valves: current challenges and future research perspectives. J Biomed Mater Res 47 4 (1999) 439-465
4. Schoen F.J., and Levy R.J. Calcification of tissue heart valve substitutes: progress toward understanding and prevention. Ann Thorac Surg 79 3 (2005) 1072-1080
5. Carpentier A., Lemaigre G., Robert L., Carpentier S., and Dubost C. Biological factors affecting long-term results of valvular heterografts. J Thorac Cardiovasc Surg 58 4 (1969) 467-483
6. Dahm M., Husmann M., Eckhard M., Prufer D., Groh E., and Oelert H. Relevance of immunologic reactions for tissue failure of bioprosthetic heart valves. Ann Thorac Surg 60 2 Suppl. (1995) S348-S352
7. Nimni M.E., Cheung D., Strates B., Kodama M., and Sheikh K. Chemically modified collagen: a natural biomaterial for tissue replacement. J Biomed Mater Res 21 6 (1987) 741-771
8. Simionescu D.T., Lovekamp J.J., and Vyavahare N.R. Degeneration of bioprosthetic heart valve cusp and wall tissues is initiated during tissue preparation: an ultrastructural study. J Heart Valve Dis 12 2 (2003) 226-234
9. Vyavahare N., Ogle M., Schoen F.J., Zand R., Gloeckner D.C., Sacks M., et al. Mechanisms of bioprosthetic heart valve failure: fatigue causes collagen denaturation and glycosaminoglycan loss. J Biomed Mater Res 46 1 (1999) 44-50
10. Lovekamp J.J., Simionescu D.T., Mercuri J.J., Zubiate B., Sacks M.S., and Vyavahare N.R. Stability and function of glycosaminoglycans in porcine bioprosthetic heart valves. Biomaterials 27 8 (2006) 1507-1518
11. Mercuri J.J., Lovekamp J.J., Simionescu D.T., and Vyavahare N.R. Glycosaminoglycan-targeted fixation for improved bioprosthetic heart valve stabilization. Biomaterials 28 3 (2007) 496-503
12. Simionescu D.T., Lovekamp J.J., and Vyavahare N.R. Glycosaminoglycan-degrading enzymes in porcine aortic heart valves: implications for bioprosthetic heart valve degeneration. J Heart Valve Dis 12 2 (2003) 217-225
13. Simionescu D.T., Lovekamp J.J., and Vyavahare N.R. Extracellular matrix degrading enzymes are active in porcine stentless aortic bioprosthetic heart valves. J Biomed Mater Res A 66 4 (2003) 755-763
14. Lovekamp J., and Vyavahare N. Periodate-mediated glycosaminoglycan stabilization in bioprosthetic heart valves. J Biomed Mater Res 56 4 (2001) 478-486
15. Raghavan D., Simionescu D.T., and Vyavahare N.R. Neomycin prevents enzyme-mediated glycosaminoglycan degradation in bioprosthetic heart valves. Biomaterials 28 18 (2007) 2861-2868
16. Shah S.R., and Vyavahare N.R. The effect of glycosaminoglycan stabilization on tissue buckling in bioprosthetic heart valves. Biomaterials 29 11 (2008) 1645-1653
17. Isenburg J.C., Karamchandani N.V., Simionescu D.T., and Vyavahare N.R. Structural requirements for stabilization of vascular elastin by polyphenolic tannins. Biomaterials 27 19 (2006) 3645-3651
18. Isenburg J.C., Simionescu D.T., and Vyavahare N.R. Elastin stabilization in cardiovascular implants: improved resistance to enzymatic degradation by treatment with tannic acid. Biomaterials 25 16 (2004) 3293-3302
19. Isenburg J.C., Simionescu D.T., and Vyavahare N.R. Tannic acid treatment enhances biostability and reduces calcification of glutaraldehyde fixed aortic wall. Biomaterials 26 11 (2005) 1237-1245
20. Starcher B.C. Determination of the elastin content of tissues by measuring desmosine and isodesmosine. Anal Biochem 79 1-2 (1977) 11-15
21. Elson L.A., and Morgan W.T. A colorimetric method for the determination of glucosamine and chondrosamine. Biochem J 27 6 (1933) 1824-1828
22. Simionescu D.T. Prevention of calcification in bioprosthetic heart valves: challenges and perspectives. Expert Opin Biol Ther 4 12 (2004) 1971-1985
23. Sacks M.S. Biomechanics of engineered heart valve tissues. Conf Proc IEEE Eng Med Biol Soc 1 (2006) 853-854
24. Grande K.J., Cochran R.P., Reinhall P.G., and Kunzelman K.S. Stress variations in the human aortic root and valve: the role of anatomic asymmetry. Ann Biomed Eng 26 4 (1998) 534-545
25. Zilla P., Brink J., Human P., and Bezuidenhout D. Prosthetic heart valves: catering for the few. Biomaterials 29 4 (2007) 385-406
26. Zilla P., Human P., and Bezuidenhout D. Bioprosthetic heart valves: the need for a quantum leap. Biotechnol Appl Biochem 40 Pt. 1 (2004) 57-66
27. Vesely I., Casarotto D.C., and Gerosa G. Mechanics of cryopreserved aortic and pulmonary homografts. J Heart Valve Dis 9 1 (2000) 27-37
28. Menzel E.J., and Farr C. Hyaluronidase and its substrate hyaluronan: biochemistry, biological activities and therapeutic uses. Cancer Lett 131 1 (1998) 3-11
29. Zhong S.P., Campoccia D., Doherty P.J., Williams R.L., Benedetti L., and Williams D.F. Biodegradation of hyaluronic acid derivatives by hyaluronidase. Biomaterials 15 5 (1994) 359-365
30. Padera F.S.a.R. Cardiac surgical pathology (2003), McGraw Hill, New York
31. Scott M., and Vesely I. Aortic valve cusp microstructure: the role of elastin. Ann Thorac Surg 60 2 Suppl. (1995) S391-S394
32. Vesely I. The role of elastin in aortic valve mechanics. J Biomech 31 2 (1998) 115-123
33. Lee T.C., Midura R.J., Hascall V.C., and Vesely I. The effect of elastin damage on the mechanics of the aortic valve. J Biomech 34 2 (2001) 203-210
34. Eichinger W., Dabritz S., and Lange R. Update of the European standards for inactive surgical implants in the area of heart valve prostheses. Eur J Cardiothorac Surg 32 5 (2007) 690-695
35. Vesely I. The evolution of bioprosthetic heart valve design and its impact on durability. Cardiovasc Pathol 12 5 (2003) 277-286